Skip to main content
. 2018 Aug 23;26(7):1031–1036. doi: 10.3727/096504018X15151523767752

Figure 1.

Figure 1

Flowchart of the patient selection process. Patients positive for EGFR mutation treated with tyrosine kinase inhibitors were included in the study.